Scancell Holdings (AQSE:SCLP.GB) Days Sales Outstanding : 0.00 (As of Oct. 2023)

View and export this data going back to 2013. Start your Free Trial

What is Scancell Holdings Days Sales Outstanding?

Scancell Holdings's average Accounts Receivable for the six months ended in Oct. 2023 was £0.51 Mil. Scancell Holdings's Revenue for the six months ended in Oct. 2023 was £0.00 Mil.

The historical rank and industry rank for Scancell Holdings's Days Sales Outstanding or its related term are showing as below:

AQSE:SCLP.GB' s Days Sales Outstanding Range Over the Past 10 Years
Min: 41.03 Med: 41.03 Max: 41.03
Current: 41.03

During the past 13 years, Scancell Holdings's highest Days Sales Outstanding was 41.03. The lowest was 41.03. And the median was 41.03.

AQSE:SCLP.GB's Days Sales Outstanding is ranked better than
76.37% of 893 companies
in the Biotechnology industry
Industry Median: 72.43 vs AQSE:SCLP.GB: 41.03

Scancell Holdings's Days Sales Outstanding declined from Oct. 2022 (108.35) to Oct. 2023 (0.00).

Scancell Holdings Days Sales Outstanding Historical Data

The historical data trend for Scancell Holdings's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Scancell Holdings Days Sales Outstanding Chart

Scancell Holdings Annual Data

Trend

Apr14

Apr15

Apr16

Apr17

Apr18

Apr19

Apr20

Apr21

Apr22

Apr23

Days Sales Outstanding

Get a 7-Day Free Trial

41.03

Scancell Holdings Semi-Annual Data
	Apr14	Oct14	Apr15	Oct15	Apr16	Oct16	Apr17	Oct17	Apr18	Oct18	Apr19	Oct19	Apr20	Oct20	Apr21	Oct21	Apr22	Oct22	Apr23	Oct23
Days Sales Outstanding	Get a 7-Day Free Trial															-	-	108.35	-	-

Competitive Comparison of Scancell Holdings's Days Sales Outstanding

For the Biotechnology subindustry, Scancell Holdings's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Scancell Holdings's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Scancell Holdings's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Scancell Holdings's Days Sales Outstanding falls into.

Scancell Holdings Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Scancell Holdings's Days Sales Outstanding for the fiscal year that ended in Apr. 2023 is calculated as

	Days Sales Outstanding (A: Apr. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Apr. 2022 )	+	Accounts Receivable (A: Apr. 2023 ))	/	count )	/	Revenue (A: Apr. 2023 )	*	Days in Period
=	( (0.647	+	0.538)	/	2 )	/	5.271	*	365
=	0.5925					/	5.271	*	365
=	41.03

Scancell Holdings's Days Sales Outstanding for the quarter that ended in Oct. 2023 is calculated as:

	Days Sales Outstanding (Q: Oct. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Apr. 2023 )	+	Accounts Receivable (A: Oct. 2023 ))	/	count )	/	Revenue (A: Oct. 2023 )	*	Days in Period
=	( (0.538	+	0.476)	/	2 )	/	0	*	365 / 2
=	0.507					/	0	*	365 / 2
=	N/A

Scancell Holdings (AQSE:SCLP.GB) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Scancell Holdings Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Scancell Holdings's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Scancell Holdings (AQSE:SCLP.GB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Scancell Holdings PLC (AQSE:SCLP.GB) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

SCLP:UK SCP:Germany

Address

Sanders Road, Unit 202, Bellhouse Building, Oxford Science Park, Oxford, GBR, OX4 4GD

Website

https://www.scancell.co.uk

Scancell Holdings PLC is engaged in the discovery and development of novel vaccines for the treatment of cancer. The company is exploiting the unrivalled potential of the immune system to seek out and destroy cancer using two proprietary immuno-oncology platforms: ImmunoBody and Moditope. Its potent innovative DNA-based ImmunoBody therapies generate ultra-high avidity T cell responses that target and eliminate cancerous tumors. Its Moditope platform technology overcomes the immune suppression induced by tumors themselves, allowing activated T cells to seek out and kill tumor cells that would otherwise be hidden from the immune system.

Scancell Holdings (AQSE:SCLP.GB) Headlines

No Headlines